MedTrace Logo

Guided Self-help for Binge Eating

NCT01832792 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 122

Last updated 2017-04-04

No results posted yet for this study

Summary

Guided self-help (GSH) is a recommended first-step treatment for bulimia nervosa, binge eating disorder, and atypical variants of these disorders. The current study proposes to investigate the effectiveness of providing GSH either face-to-face or via e-mail, also using a delayed treatment control condition. Symptom outcomes will be assessed, and an estimate of cost-effectiveness made. Results are proposed to be disseminated locally and internationally (through submission to conferences and peer-reviewed journals), and will hopefully inform local service provision.

Please note that we are only able to offer the intervention to individuals who are currently registered with a General Practitioner that is covered by Oxford Health NHS Foundation Trust - this is typically restricted to practices in Oxfordshire, Buckinghamshire, and parts of Wiltshire.

Conditions

  • Bulimia Nervosa
  • Eating Disorder Not Otherwise Specified
  • Binge Eating Disorder

Interventions

OTHER

Face-to-face self-help

Participants in this arm will receive face-to-face self-help; that is, self-help with the support of a therapist, attending the clinic in person.

OTHER

E-mail self-help

Participants in this arm will receive e-mail self-help; that is, self-help with the support of a therapist, provided via e-mail.

OTHER

Waiting List

Waiting list condition - participants assigned to a waiting list (no intervention) condition

Sponsors & Collaborators

  • Oxford Health NHS Foundation Trust

    lead OTHER_GOV

Principal Investigators

  • Paul E Jenkins, DClinPsychol · Oxford Health NHS Foundation Trust

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Model
PARALLEL

Eligibility

Min Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-08-31
Primary Completion
2017-03-31
Completion
2017-03-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01832792 on ClinicalTrials.gov